Inhaled Pharmaceutical Product Development Perspectives (ePub)

Name: Inhaled Pharmaceutical Product Development Perspectives
Brand: Elsevier Science & Techn.
SKU: 93826386
Price: 66.80 EUR
Availability: OnlineOnly

Challenges and Opportunities (Sprache: Englisch)

Autor: Anthony J. Hickey

Schreiben Sie einen Kommentar zu "Inhaled Pharmaceutical Product Development Perspectives".

Inhaled Pharmaceutical Product Development Perspectives, Anthony J. Hickey

Merken

Inhaled Pharmaceutical Product Development Perspectives: Challenges and Opportunities describes methods and procedures for consideration when developing inhaled pharmaceuticals, while commenting on product development strategies and their suitability to...

Mehr zum Inhalt Autorenporträt Video

sofort als Download lieferbar

Bestellnummer: 93826386

eBook (ePub) 66.80 €

Download bestellen

Verschenken

Lastschrift, Kreditkarte, Paypal, Rechnung
Kostenloser tolino webreader

Produktdetails

Produktbeschreibung
Autorenporträt
eBook Hilfe
Biblio. Angaben / Produktdetails
Download-DRM Infos

Produktinformationen zu „Inhaled Pharmaceutical Product Development Perspectives (ePub)“

Inhaled Pharmaceutical Product Development Perspectives: Challenges and Opportunities describes methods and procedures for consideration when developing inhaled pharmaceuticals, while commenting on product development strategies and their suitability to support regulatory submission. It bridges the gap between the aspirations of scientists invested in new technology development and the requirements that must be met for any new product.

The book brings together emerging analytical and inhalation technologies, providing perspectives that illuminate formulation and device design, development, regulatory compliance, and practice. Focusing on underlying scientific and technical principles known to be acceptable from the current regulatory perspective, this monograph will remain useful as a high-level guide to inhaled product development for the foreseeable future.

Discusses development strategies and best practices in the context of regulatory requirements
Written by a broadly qualified expert drawing on the knowledge and critical opinions of key individuals in the field
Includes a foreword by Charles G. Thiel

Autoren-Porträt von Anthony J. Hickey

Anthony J. Hickey, PhD, DSc, currently serves as a distinguished fellow and senior research pharmacologist at RTI International. He has more than 30 years of academic and research experience in the areas of pulmonary biology, aerosol physics, powder dynamics, pharmacokinetics and drug disposition, formulation design, and device development. His research has focused on improving understanding of the physiology, pharmacology, and immunology of the lungs. Throughout his career, Dr. Hickey has worked on intranasal and inhaled vaccine development and drug delivery for diseases affecting the respiratory tract, including asthma, chronic obstructive lung disease, tuberculosis, and cystic fibrosis. He has also studied the performance of powders and particles in drug and vaccine delivery systems. He received his PhD and DSc degrees in pharmaceutical sciences from the University of Aston in Birmingham, a master's degree in toxicology from the University of Birmingham, and a bachelor's degree in biology from Portsmouth Polytechnic.

eBook Hilfe

Informationen und Hilfe zu eBooks hier klicken!

Bibliographische Angaben

Autor: Anthony J. Hickey
2017, 110 Seiten, Englisch
Verlag: Elsevier Science & Techn.
ISBN-10: 0128123362
ISBN-13: 9780128123362
Erscheinungsdatum: 23.11.2017

Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.

eBook Informationen

Dateiformat: ePub
Größe: 4.12 MB
Mit Kopierschutz
Vorlesefunktion

Sprache:

Englisch

Kopierschutz

Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.

Kommentar zu "Inhaled Pharmaceutical Product Development Perspectives"

Schreiben Sie einen Kommentar zu "Inhaled Pharmaceutical Product Development Perspectives".